Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021.

Journal of the National Comprehensive Cancer Network : JNCCN

Abu-Rustum NR, Yashar CM, Bradley K, Campos SM, Chino J, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Diver E, Fisher CM, Frederick P, Gaffney DK, George S, Giuntoli R, Han E, Howitt B, Huh WK, Lea J, Mariani A, Mutch D, Nekhlyudov L, Podoll M, Remmenga SW, Reynolds RK, Salani R, Sisodia R, Soliman P, Tanner E, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian NR, Motter AD.
PMID: 34416706
J Natl Compr Canc Netw. 2021 Aug 01;19(8):888-895. doi: 10.6004/jnccn.2021.0038.

The NCCN Guidelines for Uterine Neoplasms provide recommendations for diagnostic workup, clinical staging, and treatment options for patients with endometrial cancer or uterine sarcoma. These NCCN Guidelines Insights focus on the recent addition of molecular profiling information to aid...

Cite
Abu-Rustum NR, Yashar CM, Bradley K, et al. NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021. J Natl Compr Canc Netw. 2021;19(8):888-895doi: 10.6004/jnccn.2021.0038.
Abu-Rustum, N. R., Yashar, C. M., Bradley, K., Campos, S. M., Chino, J., Chon, H. S., Chu, C., Cohn, D., Crispens, M. A., Damast, S., Diver, E., Fisher, C. M., Frederick, P., Gaffney, D. K., George, S., Giuntoli, R., Han, E., Howitt, B., Huh, W. K., Lea, J., Mariani, A., Mutch, D., Nekhlyudov, L., Podoll, M., Remmenga, S. W., Reynolds, R. K., Salani, R., Sisodia, R., Soliman, P., Tanner, E., Ueda, S., Urban, R., Wethington, S. L., Wyse, E., Zanotti, K., McMillian, N. R., & Motter, A. D. (2021). NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021. Journal of the National Comprehensive Cancer Network : JNCCN, 19(8), 888-895. https://doi.org/10.6004/jnccn.2021.0038
Abu-Rustum, Nadeem R, et al. "NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021." Journal of the National Comprehensive Cancer Network : JNCCN vol. 19,8 (2021): 888-895. doi: https://doi.org/10.6004/jnccn.2021.0038
Abu-Rustum NR, Yashar CM, Bradley K, Campos SM, Chino J, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Diver E, Fisher CM, Frederick P, Gaffney DK, George S, Giuntoli R, Han E, Howitt B, Huh WK, Lea J, Mariani A, Mutch D, Nekhlyudov L, Podoll M, Remmenga SW, Reynolds RK, Salani R, Sisodia R, Soliman P, Tanner E, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian NR, Motter AD. NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021. J Natl Compr Canc Netw. 2021 Aug 01;19(8):888-895. doi: 10.6004/jnccn.2021.0038. PMID: 34416706.
Copy Download .nbib Format: NLM
Impact of immediate evaluation of touch imprint cytology from computed tomography guided core needle biopsies of mass lesions: Single institution experience.

CytoJournal

Moghadamfalahi M, Podoll M, Frey AB, Alatassi H.
PMID: 25071857
Cytojournal. 2014 Jun 12;11:15. doi: 10.4103/1742-6413.134437. eCollection 2014.

BACKGROUND: Computed tomography (CT) guided core needle biopsy (CT-guided CNB) is a minimally invasive, safe and effective manner of tissue sampling in many organs. The aim of our study is to determine the impact of on-site evaluation of touch...

Cite
Moghadamfalahi M, Podoll M, Frey AB, et al. Impact of immediate evaluation of touch imprint cytology from computed tomography guided core needle biopsies of mass lesions: Single institution experience. Cytojournal. 2014;11:15doi: 10.4103/1742-6413.134437.
Moghadamfalahi, M., Podoll, M., Frey, A. B., & Alatassi, H. (2014). Impact of immediate evaluation of touch imprint cytology from computed tomography guided core needle biopsies of mass lesions: Single institution experience. CytoJournal, 1115. https://doi.org/10.4103/1742-6413.134437
Moghadamfalahi, Mana, et al. "Impact of immediate evaluation of touch imprint cytology from computed tomography guided core needle biopsies of mass lesions: Single institution experience." CytoJournal vol. 11 (2014): 15. doi: https://doi.org/10.4103/1742-6413.134437
Moghadamfalahi M, Podoll M, Frey AB, Alatassi H. Impact of immediate evaluation of touch imprint cytology from computed tomography guided core needle biopsies of mass lesions: Single institution experience. Cytojournal. 2014 Jun 12;11:15. doi: 10.4103/1742-6413.134437. eCollection 2014. PMID: 25071857; PMCID: PMC4104541.
Copy Download .nbib Format: NLM
Records and forms.

Pediatric clinics of North America

PODOLL E.
PMID: 13736478
Pediatr Clin North Am. 1961 Feb;8:389-96. doi: 10.1016/s0031-3955(16)31098-7.

No abstract available.

Cite
PODOLL E. Records and forms. Pediatr Clin North Am. 1961;8:389-96doi: 10.1016/s0031-3955(16)31098-7.
PODOLL, E. (1961). Records and forms. Pediatric clinics of North America, 8389-96. https://doi.org/10.1016/s0031-3955(16)31098-7
PODOLL, E. "Records and forms." Pediatric clinics of North America vol. 8 (1961): 389-96. doi: https://doi.org/10.1016/s0031-3955(16)31098-7
PODOLL E. Records and forms. Pediatr Clin North Am. 1961 Feb;8:389-96. doi: 10.1016/s0031-3955(16)31098-7. PMID: 13736478.
Copy Download .nbib Format: NLM
Isolated subcutaneous recurrence of high-grade neuroendocrine tumor of the cervix.

Gynecologic oncology reports

Bos L, Goulder A, Prescott L, Podoll M, Frumovitz M, Brown AJ.
PMID: 34095421
Gynecol Oncol Rep. 2021 May 07;37:100780. doi: 10.1016/j.gore.2021.100780. eCollection 2021 Aug.

•This case reports an isolated subcutaneous recurrence of neuroendocrine carcinoma of the cervix.•Multiple recurrences of NECC were treated surgically without additional systemic therapy.•There is a need for further studies to evaluate optimal treatment regimens for NECC.

Cite
Bos L, Goulder A, Prescott L, et al. Isolated subcutaneous recurrence of high-grade neuroendocrine tumor of the cervix. Gynecol Oncol Rep. 2021;37:100780doi: 10.1016/j.gore.2021.100780.
Bos, L., Goulder, A., Prescott, L., Podoll, M., Frumovitz, M., & Brown, A. J. (2021). Isolated subcutaneous recurrence of high-grade neuroendocrine tumor of the cervix. Gynecologic oncology reports, 37100780. https://doi.org/10.1016/j.gore.2021.100780
Bos, Lia, et al. "Isolated subcutaneous recurrence of high-grade neuroendocrine tumor of the cervix." Gynecologic oncology reports vol. 37 (2021): 100780. doi: https://doi.org/10.1016/j.gore.2021.100780
Bos L, Goulder A, Prescott L, Podoll M, Frumovitz M, Brown AJ. Isolated subcutaneous recurrence of high-grade neuroendocrine tumor of the cervix. Gynecol Oncol Rep. 2021 May 07;37:100780. doi: 10.1016/j.gore.2021.100780. eCollection 2021 Aug. PMID: 34095421; PMCID: PMC8165541.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries